Phathom Pharmaceuticals I... (PHAT)
NASDAQ: PHAT
· Real-Time Price · USD
10.46
-0.01 (-0.10%)
At close: Aug 15, 2025, 1:23 PM
13F Institute Ownership
Total Institutes of 140 in Phathom Pharmaceuticals reduced their positions with a decrease of 8 investors compared to the previous quarter. A reduction of 3.47M shares, as total invested capital declined by $144.96M with ownership percentage dropping from 103.17% to 87.82%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.599
0.60
Call Flow 92,700
63%
Put Flow 55,500
37%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Manageme... | 14.05% | 10.11M | +0.00% | 63.39M | 2.90% | May 15, 2025 |
| Medicxi Ventures Management (j... | 10.37% | 7.46M | +0.00% | 46.8M | 10.69% | Apr 11, 2025 |
| Jennison Associates LLC | 9.79% | 7.04M | -0.29% | 44.16M | 0.03% | May 05, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.